default author photo

Carla della Ventura

Università degli Studi di Milano

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

95

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Genomic Epidemiology and Phylogeographic Reconstruction of West Nile Virus 2 in Italy from 2011 to 2023

Number of pages: 24 Posted: 29 Jul 2025
Università degli Studi di Milano, affiliation not provided to SSRN, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Milan, Università degli Studi di Milano, University of Milan, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna and University of Milan
Downloads 36 (1,249,711)

Abstract:

Loading...

west nile virus, lineage 2, whole genome sequencing, Epidemiology, phylogeographical approach

2.

In vitro Characterization of Peptidomimetic Proteolysis Targeting Chimera (PROTAC) as a Degrader of 3-Chymotrypsin-Like Protease (Mpro/3CLpro) against SARS-CoV-2

Number of pages: 10 Posted: 04 Nov 2025
affiliation not provided to SSRN, Università degli Studi di Milano, University of Milan, Università degli Studi di Milano, affiliation not provided to SSRN, Università degli Studi di Milano, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Milan - DIBIC “Luigi Sacco”
Downloads 30 (1,332,057)

Abstract:

Loading...

SARS-CoV2, Protease inhibitors, PROTAC, In vitro

3.

Exploring Early Covid-19 Therapies, Variants, and Viral Clearance Dynamics: Insights from a High-Risk Outpatients Study

Number of pages: 14 Posted: 15 May 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Milan, Università degli Studi di Milano, Università degli Studi di Milano, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 29 (1,332,057)

Abstract:

Loading...

COVID-19, Early Therapies, Variant of Concern, Viral clearance